The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Eric P. Brass

Department of Medicine

Harbor-University of California Los Angeles Medical Center

1124 W. Carson St.

Torrance

USA

[email]@ucla.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Harbor-University of California Los Angeles Medical Center, 1124 W. Carson St., Torrance, USA. 2001 - 2010
  • Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA. 2009
  • Harbor-UCLA Center for Clinical Pharmacology, Torrance, California, USA. 2001 - 2008
  • Department of Medicine, Center for Clinical Pharmacology, Harbor-UCLA Medical Center, Torrance, USA. 2003 - 2004

References

  1. The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making. Brass, E.P. Clin. Pharmacol. Ther. (2010) [Pubmed]
  2. Temporal pattern of skeletal muscle gene expression following endurance exercise in Alaskan sled dogs. Brass, E.P., Peters, M.A., Hinchcliff, K.W., He, Y.D., Ulrich, R.G. J. Appl. Physiol. (2009) [Pubmed]
  3. Analysis of multiple end points in consumer research in support of switching drugs from prescription to over-the-counter status: the concept of end-point hierarchies. Brass, E.P., Shay, L.E., Leonard-Segal, A. Clin. Pharmacol. Ther. (2009) [Pubmed]
  4. Basic biomedical sciences and the future of medical education: implications for internal medicine. Brass, E.P. J. Gen. Intern. Med (2009) [Pubmed]
  5. Can consumers self-select for appropriate use of an over-the-counter statin? The Self Evaluation of Lovastatin to Enhance Cholesterol Treatment Study. Brass, E.P., Vassil, T., Replogle, A., Hwang, P., Rusche, S., Shiffman, S., Levine, J.G. Am. J. Cardiol. (2008) [Pubmed]
  6. Optimal assessment of baseline treadmill walking performance in claudication clinical trials. Brass, E.P., Jiao, J., Hiatt, W. Vasc. Med (2007) [Pubmed]
  7. Potential impact on cardiovascular public health of over-the-counter statin availability. Brass, E.P., Allen, S.E., Melin, J.M. Am. J. Cardiol. (2006) [Pubmed]
  8. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. Brass, E.P., Anthony, R., Dormandy, J., Hiatt, W.R., Jiao, J., Nakanishi, A., McNamara, T., Nehler, M. J. Vasc. Surg. (2006) [Pubmed]
  9. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease. Brass, E.P., Anthony, R., Cobb, F.R., Koda, I., Jiao, J., Hiatt, W.R. J. Am. Coll. Cardiol. (2006) [Pubmed]
  10. Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies. Brass, E.P., Hiatt, W.R. Vasc. Med (2006) [Pubmed]
  11. Implications of a switch from prescription to over-the-counter status for allergy drugs. Brass, E.P. Curr. Allergy. Asthma. Rep (2004) [Pubmed]
  12. Consumer behavior in the setting of over-the-counter statin availability: lessons from the consumer use study of OTC Mevacor. Brass, E.P. Am. J. Cardiol. (2004) [Pubmed]
  13. Carnitine and sports medicine: use or abuse?. Brass, E.P. Ann. N. Y. Acad. Sci. (2004) [Pubmed]
  14. Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil. Brass, E.P., Mayer, M.D., Mulford, D.J., Stickler, T.K., Hoppel, C.L. Clin. Pharmacol. Ther. (2003) [Pubmed]
  15. Label development and the label comprehension study for over-the-counter drugs. Brass, E.P., Weintraub, M. Clin. Pharmacol. Ther. (2003) [Pubmed]
  16. Peripheral arterial disease is not associated with an increased prevalence of intradialytic cramps in patients on maintenance hemodialysis. Brass, E.P., Adler, S., Sietsema, K.E., Amato, A., Esler, A., Hiatt, W.R. Am. J. Nephrol. (2002) [Pubmed]
  17. Pivalate-generating prodrugs and carnitine homeostasis in man. Brass, E.P. Pharmacol. Rev. (2002) [Pubmed]
  18. Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease. Brass, E.P., Hiatt, W.R., Gardner, A.W., Hoppel, C.L. Am. J. Physiol. Heart Circ. Physiol. (2001) [Pubmed]
  19. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Brass, E.P., Adler, S., Sietsema, K.E., Hiatt, W.R., Orlando, A.M., Amato, A. Am. J. Kidney Dis. (2001) [Pubmed]
  20. Changing the status of drugs from prescription to over-the-counter availability. Brass, E.P. N. Engl. J. Med. (2001) [Pubmed]
  21. Implementation of a data and safety monitoring program in a general clinical research center. Brass, E.P. J. Investig. Med. (2001) [Pubmed]
 
WikiGenes - Universities